DNA Copy Number Changes and Evaluation of MYC, IGF1R, and FES Amplification in Xenografts of Pancreatic Adenocarcinoma
- 1 January 2000
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 116 (2) , 133-141
- https://doi.org/10.1016/s0165-4608(99)00118-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrationsGenes, Chromosomes and Cancer, 1998
- Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancerGenes, Chromosomes and Cancer, 1997
- Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinomaGenes, Chromosomes and Cancer, 1997
- The national cancer data base report on pancreatic cancerCancer, 1995
- Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomasGenes, Chromosomes and Cancer, 1995
- Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21–q22 in soft tissue sarcomasGenes, Chromosomes and Cancer, 1995
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumorsGenes, Chromosomes and Cancer, 1994
- Karyotypic abnormalities in tumours of the pancreasBritish Journal of Cancer, 1993
- Nonrandom chromosomal rearrangements in pancreatic carcinomasCancer, 1992